Platinum Compounds

Platinum Compounds is a class of antineoplastic agents characterized by a core platinum atom coordinated to ligands that enable DNA cross-linking, thereby inhibiting cancer cell replication and inducing apoptosis.

14.6K

Publications

700.8K

Citations

41.1K

Authors

5.6K

Institutions

Publications per year

2017–2026

2.2K

Variants

Platinum-based Antineoplastic AgentsPlatinum-based Drugs

Authors

41.1K

  1. SJ
    Stephen J. Lippard

    Massachusetts Institute of Technology, United States

    125 publications · 14.4K citations

    64

    h-index

  2. CC
    Chi‐Ming Che

    University of Hong Kong, Hong Kong SAR China

    99 publications · 11K citations

    62

    h-index

  3. NP
    Nicholas P. Farrell

    Virginia Commonwealth University, United States

    147 publications · 8.1K citations

    57

    h-index

  4. PJ
    Peter J. Sadler

    University of Warwick, United Kingdom

    109 publications · 8.5K citations

    51

    h-index

  5. VB
    Viktor Brabec

    Czech Academy of Sciences, Institute of Biophysics, Czechia

    131 publications · 6.5K citations

    50

    h-index

1–5 of 41.1K

Venues

  1. Journal of the American Chemical Society

    JACS · 604 publications · 49.1K citations

    114

    h-index

  2. Inorganic Chemistry

    1.2K publications · 58.8K citations

    95

    h-index

  3. Angewandte Chemie International Edition

    184 publications · 16.7K citations

    80

    h-index

  4. PubMed

    Repository · 474 publications · 26.8K citations

    80

    h-index

  5. Organometallics

    629 publications · 27K citations

    76

    h-index

1–5